Brief observationFailure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture
Section snippets
Patients and methods
We performed a retrospective chart review of all elderly (≥65 years) patients admitted with the principal diagnosis of hip fracture to the orthopedic unit at the Nassau County Medical Center (a 600-bed tertiary care, level-I trauma hospital) in Long Island, New York, from January 1, 1996, to December 31, 1998. The hospital is a major teaching affiliate of the State University of New York at Stony Brook Health Sciences Center and has residency programs in internal medicine and orthopedics, as
Results
A total of 170 patients were included in the study (Table 1). Half of the patients fractured their right hip, 49% fractured their left hip, and 1 patient fractured both hips. Nineteen (11%) patients had other associated fractures; the most common was a fractured wrist, which occurred in 7 patients. A fall was the most common cause of hip fracture (155 [91%] of cases); other causes included road traffic accidents (10 [6%]) and other trauma (5 [3%]). A prior diagnosis of osteoporosis was recorded
Discussion
The occurrence of a nontraumatic hip fracture in an older adult is almost always due to osteoporosis 22, 23. Following the first hip fracture, the rate of a second hip fracture in women increases sixfold, from 3.6 to 22 per 1,000 person-years (7). Several medications—including calcium 11, 12, 13, vitamin D 12, 13, alendronate 14, 15, 16, 17, and estrogen 18, 19—have been shown to decrease fracture risk. Nevertheless, rates of utilization of these therapies were low.
More recently, raloxifene, a
References (25)
- et al.
Hip fracture
Clin Geriatr Med
(1994) - et al.
Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group
Lancet
(1996) - et al.
Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism
Am J Med
(1998) - et al.
New drugs—reports of new drugs recently approved by the FDA. Alendronate
Bioorg Med Chem
(1996) - et al.
Lifetime risks of hip, collar or vertebral fracture and coronary artery disease among white postmenopausal women
Arch Intern Med
(1989) - et al.
Age-related osteoporosis
Clin Geriatr Med
(1994) - et al.
Medical expenditure for the treatment of osteoporotic fractures in the United States in 1995report from the National Osteoporotic Foundation
J Bone Miner Res
(1997) Osteoporosis, and aging. Etiology and current diagnostic strategies
Ann Long-Term Care
(1998)Prophylaxis and treatment of osteoporosis
Am J Med
(1991)- Schroder HM, Petersen KK, Erlandsen M. Occurrence and incidence of the second hip fracture. Clin Orthop....
Observations on nursing home residents with a history of hip fracture
Am J Med Sci
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture
JAMA
Cited by (243)
Orthopedic Surgery and the Geriatric Patient
2019, Clinics in Geriatric MedicineOsteoporosis in the Women's Health Initiative: Another Treatment Gap?
2017, American Journal of MedicineCare Processes:Using a Triggered Endocrinology Service Consultation to Improve the Evaluation, Management, and Follow-Up of Osteoporosis in Hip-Fracture Patients
2014, Joint Commission Journal on Quality and Patient SafetyCitation Excerpt :An Institutional Review Board waiver of individual informed consent was obtained from the UC San Diego Health System. Our first step was a literature review to identify best practices for management of osteoporosis in patients hospitalized for fragility fractures.11,19–22 We incorporated the following best-practice recommendations into our protocol4,23: